MMP9 and breast cancer: Simultaneously, N2-TANs initiate tumor cell growth as well as angiogenesis via a CD90-TIMP-1 loop and the G-CSF-RLN2-MMP-9 axis in breast cancer and suppress a cytotoxic immune response [6,12,13].